KRAS is the most recurrently mutated gene (86% of RAS-mutant cancers) [2,3] and is a driver gene that is particularly involved in the development and progression of pancreatic (PDAC), lung and colorectal (CRC) cancers (for recent reviews see [4,5]). The gene discussed is KRAS; the disease is colorectal carcinoma.